Advanced search
Publication Cover
International Journal of Nanomedicine Volume 14, 2019 - Issue
Submit an article Journal homepage
425
Views
55
CrossRef citations to date
0
Altmetric
Original Research

PD-L1 monoclonal antibody-conjugated nanoparticles enhance drug delivery level and chemotherapy efficacy in gastric cancer cells

Shijie Xu1 Center for Public Health Research, Medical School, Nanjing University, Nanjing, China
,
Fangbo Cui2 Department of Oncology, Wannan Medical College, Wuhu, Anhui, China, [email protected];3 Department of Oncology, The People’s Hospital of Ma Anshan, Ma Anshan, Anhui, China, [email protected]Correspondence[email protected]
,
Dafu Huang4 Department of Oncology, Nanjing Lishui People’s Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, Jiangsu, China
,
Dinghu Zhang5 Department of Oncology, Tongde Hospital of Zhejiang Province, Hangzhou, China
,
Anqing Zhu6 Department of Oncology, The Affliated Jiangyin Hospital of Southeast University Medical College, Jiangyin, Jiangsu, China
,
Xia Sun6 Department of Oncology, The Affliated Jiangyin Hospital of Southeast University Medical College, Jiangyin, Jiangsu, China
,
Yiming Cao7 Department of General Surgery, The People’s Hospital of Ma Anshan, Ma Anshan, Anhui, China
,
Sheng Ding7 Department of General Surgery, The People’s Hospital of Ma Anshan, Ma Anshan, Anhui, China
,
Yao Wang7 Department of General Surgery, The People’s Hospital of Ma Anshan, Ma Anshan, Anhui, China
,
Eryun Gao3 Department of Oncology, The People’s Hospital of Ma Anshan, Ma Anshan, Anhui, China, [email protected]
&
Fenglin Zhang3 Department of Oncology, The People’s Hospital of Ma Anshan, Ma Anshan, Anhui, China, [email protected]
 show all
Pages 17-32 | Published online: 18 Dec 2018

Citations (55)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Shuangjiu Zhu, Jingjun Sun, Xiaoqin Liu, Hua Shao, Chuanbo Feng, Zhonglin Wang, Xinwen Zheng & Shaohua Wei. (2022) CTCF-Induced lncRNA C5orf66-AS1 Facilitates the Progression of Triple-Negative Breast Cancer via Sponging miR-149-5p to Up-Regulate CTCF and CTNNB1 to Activate Wnt/β-Catenin Pathway. Molecular and Cellular Biology 42:6.
Read now
Jiachi Ma, Yuzhong Chen, Wanqing Liang, Lei Li, Jun Du, Chengwu Pan & Chensong Zhang. (2021) ROS-responsive dimeric prodrug-based nanomedicine targeted therapy for gastric cancer. Drug Delivery 28:1, pages 1204-1213.
Read now
Yu Hei, Binhong Teng, Ziqian Zeng, Siqi Zhang, Qian Li, Jijia Pan, Zuyuan Luo, Chunyang Xiong & Shicheng Wei. (2020) Multifunctional Immunoliposomes Combining Catalase and PD-L1 Antibodies Overcome Tumor Hypoxia and Enhance Immunotherapeutic Effects Against Melanoma. International Journal of Nanomedicine 15, pages 1677-1691.
Read now

Articles from other publishers (52)

Elham Seyyedi Zadeh, Narges Ghanbari, Zeinab Salehi, Sorour Derakhti, Ghassem Amoabediny, Maryam Akbari & Mohammad Asadi Tokmedash. (2023) Smart pH-responsive magnetic graphene quantum dots nanocarriers for anticancer drug delivery of curcumin. Materials Chemistry and Physics 297, pages 127336.
Crossref
João Vito Barroso de Freitas, Alice Vitoria Frota Reis, Alan Denis Olivindo Silva, Ana Carolina Cruz de Sousa, Jéssica Roberta Pereira Martins, Karina Alexandre Barros Nogueira, Thais da Silva Moreira, Raquel Petrilli & Josimar O. Eloy. 2023. Cancer Nanotechnology. Cancer Nanotechnology 115 176 .
Ana Camila Marques, Paulo Cardoso da Costa, Sérgia Velho & Maria Helena Amaral. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology 1 43 .
Anupama Ojha, Sonali Jaiswal, Priyanka Bharti & Sarad Kumar Mishra. (2022) Nanoparticles and Nanomaterials-Based Recent Approaches in Upgraded Targeting and Management of Cancer: A Review. Cancers 15:1, pages 162.
Crossref
Zerong Pei, Shuting Chen, Liqin Ding, Jingbo Liu, Xinyi Cui, Fengyun Li & Feng Qiu. (2022) Current perspectives and trend of nanomedicine in cancer: A review and bibliometric analysis. Journal of Controlled Release 352, pages 211-241.
Crossref
Yingzi Zhang, Yan Yang, Yiran Chen, Wu Lin, Xiangliu Chen, Jin Liu, Yingying Huang, Haiyong Wang & Lisong Teng. (2022) PD-L1: Biological mechanism, function, and immunotherapy in gastric cancer. Frontiers in Immunology 13.
Crossref
Rahul Kumar, Daphika S. Dkhar, Rohini Kumari, Divya, Supratim Mahapatra, Ananya Srivastava, Vikash Kumar Dubey & Pranjal Chandra. (2022) Ligand conjugated lipid‐based nanocarriers for cancer theranostics. Biotechnology and Bioengineering 119:11, pages 3022-3043.
Crossref
Elise Timon-David, Carla Perez & Anne Rodallec. (2022) Nanotherapeutics Plus Immunotherapy in Oncology: Who Brings What to the Table?. Pharmaceutics 14:11, pages 2326.
Crossref
Yi-Nan Ding, Ming Xue, Qiu-Sha Tang, Li-Jun Wang, Hui-Yan Ding, Han Li, Cheng-Cheng Gao & Wei-Ping Yu. (2022) Immunotherapy-based novel nanoparticles in the treatment of gastrointestinal cancer: Trends and challenges. World Journal of Gastroenterology 28:37, pages 5403-5419.
Crossref
Puze Li, Dongdong Wang, Jun Hu & Xiangliang Yang. (2022) The role of imaging in targeted delivery of nanomedicine for cancer therapy. Advanced Drug Delivery Reviews 189, pages 114447.
Crossref
Andrea Zanello, Massimo Bortolotti, Stefania Maiello, Andrea Bolognesi & Letizia Polito. (2022) Anti-PD-L1 immunoconjugates for cancer therapy: Are available antibodies good carriers for toxic payload delivering?. Frontiers in Pharmacology 13.
Crossref
Ming Yang, Olamide Tosin Olaoba, Chunye Zhang, Eric T. Kimchi, Kevin F. Staveley-O’Carroll & Guangfu Li. (2022) Cancer Immunotherapy and Delivery System: An Update. Pharmaceutics 14:8, pages 1630.
Crossref
Daša Zupančič & Peter Veranič. (2022) Nanodiamonds as Possible Tools for Improved Management of Bladder Cancer and Bacterial Cystitis. International Journal of Molecular Sciences 23:15, pages 8183.
Crossref
Fatemeh Movahedi, Jie Liu, Bing Sun, Pei Cao, Luyao Sun, Christopher Howard, Wenyi Gu & Zhi Ping Xu. (2022) PD-L1-Targeted Co-Delivery of Two Chemotherapeutics for Efficient Suppression of Skin Cancer Growth. Pharmaceutics 14:7, pages 1488.
Crossref
Juyoung Hwang, Eun-Koung An, Wei Zhang, Hae-Bin Park, So-Jung Kim, Dhananjay Yadav, Jihoe Kim, Inho Choi, Minseok Kwak, Peter CW. Lee, Xiaoyan Zhang, Jianqing Xu & Jun-O Jin. (2022) Recombinant programmed cell death protein 1 functions as an immune check point blockade and enhances anti-cancer immunity. Biomaterials 285, pages 121550.
Crossref
Shun‐Yu Wu, Fu‐Gen Wu & Xiaoyuan Chen. (2022) Antibody‐Incorporated Nanomedicines for Cancer Therapy. Advanced Materials 34:24.
Crossref
Tuan Hiep Tran & Thi Thu Phuong Tran. (2022) Targeting the PD-1/PD-L1 axis for cancer treatment: a review on nanotechnology. Royal Society Open Science 9:4.
Crossref
Cherylette Anne Alexander & Yi Yan Yang. (2022) Harnessing the combined potential of cancer immunotherapy and nanomedicine: A new paradigm in cancer treatment. Nanomedicine: Nanotechnology, Biology and Medicine 40, pages 102492.
Crossref
Pratigyan Dash & Mamoni Dash. 2022. Biomimetic Biomaterials for Tissue Regeneration and Drug Delivery. Biomimetic Biomaterials for Tissue Regeneration and Drug Delivery 55 73 .
Na Kyeong Lee, Chi-Pin James Wang, Jaesung Lim, Wooram Park, Ho-Keun Kwon, Se-Na Kim, Tae-Hyung Kim & Chun Gwon Park. (2021) Impact of the conjugation of antibodies to the surfaces of polymer nanoparticles on the immune cell targeting abilities. Nano Convergence 8:1.
Crossref
Qidong Zhou, Weihong Ding, Zhiyu Qian, Quangang Zhu, Chuanyu Sun, Qin Yu, Zongguang Tai & Ke Xu. (2021) Immunotherapy Strategy Targeting Programmed Cell Death Ligand 1 and CD73 with Macrophage-Derived Mimetic Nanovesicles to Treat Bladder Cancer. Molecular Pharmaceutics 18:11, pages 4015-4028.
Crossref
Ya-Kui Huang, Hong-Rui Tian, Ming-Zu Zhang, Jin-Lin He, Jian Liu & Pei-Hong Ni. (2021) Monoclonal Antibody-conjugated Polyphosphoester-hyd-DOX Prodrug Nanoparticles for Targeted Chemotherapy of Liver Cancer Cells. Chinese Journal of Polymer Science 39:11, pages 1392-1402.
Crossref
Katarzyna Lisik & Anita Krokosz. (2021) Application of Carbon Nanoparticles in Oncology and Regenerative Medicine. International Journal of Molecular Sciences 22:15, pages 8341.
Crossref
Le Minh Pham, Kishwor Poudel, Wenquan Ou, Cao Dai Phung, Hanh Thuy Nguyen, Bao Loc Nguyen, Prajeena Karmacharya, Mahesh Pandit, Jae-Hoon Chang, Jee-Heon Jeong, Sae Kwang Ku, Chul Soon Yong, Han-Gon Choi & Jong Oh Kim. (2021) Combination chemotherapeutic and immune-therapeutic anticancer approach via anti-PD-L1 antibody conjugated albumin nanoparticles. International Journal of Pharmaceutics 605, pages 120816.
Crossref
Jamileh Kadkhoda, Mohammad Akrami-Hasan-Kohal, Mohammad Reza Tohidkia, Samira Khaledi, Soodabeh Davaran & Ayuob Aghanejad. (2021) Advances in antibody nanoconjugates for diagnosis and therapy: A review of recent studies and trends. International Journal of Biological Macromolecules 185, pages 664-678.
Crossref
Xinyi Lin, Xiaoyan Wang, Qing Gu, Dongqin Lei, Xiaolong Liu & Cuiping Yao. (2021) Emerging nanotechnological strategies to reshape tumor microenvironment for enhanced therapeutic outcomes of cancer immunotherapy. Biomedical Materials 16:4, pages 042001.
Crossref
Hongrui Tian, Yakui Huang, Jinlin He, Mingzu Zhang & Peihong Ni. (2021) CD147 Monoclonal Antibody Targeted Reduction-Responsive Camptothecin Polyphosphoester Nanomedicine for Drug Delivery in Hepatocellular Carcinoma Cells. ACS Applied Bio Materials 4:5, pages 4422-4431.
Crossref
Luzhou Xu, Lei Zhu, Kai Zheng, Junlou Liu, Panpan Tian, Di Hu, Qianqian Wang, Qiaoyun Zuo, Xiaosong Ouyang, Yanna Dai, Yuxian Fu, Xinyi Dai, Fang Huang & Jun Cheng. (2021) The design and synthesis of redox-responsive oridonin polymeric prodrug micelle formulation for effective gastric cancer therapy. Journal of Materials Chemistry B 9:13, pages 3068-3078.
Crossref
Asmita Banstola, Kishwor Poudel, Fakhrossadat Emami, Sae Kwang Ku, Jee-Heon Jeong, Jong Oh Kim & Simmyung Yook. (2021) Localized therapy using anti-PD-L1 anchored and NIR-responsive hollow gold nanoshell (HGNS) loaded with doxorubicin (DOX) for the treatment of locally advanced melanoma. Nanomedicine: Nanotechnology, Biology and Medicine 33, pages 102349.
Crossref
Ganji Purnachandra Nagaraju, Gowru Srivani, Begum Dariya, Gayathri Chalikonda, Batoul Farran, Santosh Kumar Behera, Afroz Alam & Mohammad Amjad Kamal. (2021) Nanoparticles guided drug delivery and imaging in gastric cancer. Seminars in Cancer Biology 69, pages 69-76.
Crossref
Veronika Subjakova, Veronika Oravczova & Tibor Hianik. (2021) Polymer Nanoparticles and Nanomotors Modified by DNA/RNA Aptamers and Antibodies in Targeted Therapy of Cancer. Polymers 13:3, pages 341.
Crossref
Jing Chen, Yaser Alduais & Baoan Chen. (2021) Therapeutic and Systemic Adverse Events of Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 axis for Clinical Management of NSCLC. Cell Transplantation 30, pages 096368972110415.
Crossref
Jisoo Park, Sangwoo Lee, Yuseon Kim & Tae Hyeon Yoo. (2021) Methods to generate site-specific conjugates of antibody and protein. Bioorganic & Medicinal Chemistry 30, pages 115946.
Crossref
Brahmeshwar Mishra & Mansi Upadhyay. 2021. Advanced Drug Delivery Systems in the Management of Cancer. Advanced Drug Delivery Systems in the Management of Cancer 319 330 .
Shaheda Parveen, Saman Fatima, Syed Naved Quadri, Sarwar Beg & M.Z. Abdin. 2021. Nanoformulation Strategies for Cancer Treatment. Nanoformulation Strategies for Cancer Treatment 131 152 .
Kuldeep Rajpoot & Sunil K. Jain. 2021. Nano Drug Delivery Strategies for the Treatment of Cancers. Nano Drug Delivery Strategies for the Treatment of Cancers 165 189 .
Devasena T.Devasena T.. 2021. Nanotechnology-COVID-19 Interface. Nanotechnology-COVID-19 Interface 71 114 .
Siew-Wai Pang, Michiele Lee-Kiun Soon, Kamyar Shameli, Pushpamalar Janarthanan & Sin-Yeang Teow. 2021. Nanotechnology in Medicine. Nanotechnology in Medicine 199 224 .
Jin-Yu Sun, Dengke Zhang, Songquan Wu, Min Xu, Xiao Zhou, Xiao-Jie Lu & Jiansong Ji. (2020) Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives. Biomarker Research 8:1.
Crossref
Sandra Jesus, Natalia Bernardi, Jessica da Silva, Mariana Colaço, João Panão Costa, Pedro Fonte & Olga Borges. (2020) Unravelling the Immunotoxicity of Polycaprolactone Nanoparticles—Effects of Polymer Molecular Weight, Hydrolysis, and Blends. Chemical Research in Toxicology 33:11, pages 2819-2833.
Crossref
Lei Liu, Shuaichao Wang, Peilan Qi, Shiyong Song, Yanwei Yang, Jiahua Shi & Guang Han. (2020) Dopamine-modified poly(ε-caprolactone) micelles for pH controlled delivery of bortezomib. International Journal of Pharmaceutics 590, pages 119885.
Crossref
Akanksha Behl, Virinder S. Parmar, Shashwat Malhotra & Anil K. Chhillar. (2020) Biodegradable diblock copolymeric PEG-PCL nanoparticles: Synthesis, characterization and applications as anticancer drug delivery agents. Polymer 207, pages 122901.
Crossref
Yen Pin Yew, Kamyar Shameli, Shaza Eva Mohamad, Kar Xin Lee & Sin-Yeang Teow. (2020) Green Synthesized Montmorillonite/Carrageenan/Fe3O4 Nanocomposites for pH-Responsive Release of Protocatechuic Acid and Its Anticancer Activity. International Journal of Molecular Sciences 21:14, pages 4851.
Crossref
Yinghong Shi, Jiahui Zhang, Zheying Mao, Han Jiang, Wei Liu, Hui Shi, Runbi Ji, Wenrong Xu, Hui Qian & Xu Zhang. (2020) Extracellular Vesicles From Gastric Cancer Cells Induce PD-L1 Expression on Neutrophils to Suppress T-Cell Immunity. Frontiers in Oncology 10.
Crossref
Xiao-Jie Chen, Xue-Qiong Zhang, Ming-Xiu Tang, Qi Liu & Gang Zhou. (2020) Anti-PD-L1-modified and ATRA-loaded nanoparticles for immuno-treatment of oral dysplasia and oral squamous cell carcinoma. Nanomedicine 15:10, pages 951-968.
Crossref
A.C. Marques, P.J. Costa, S. Velho & M.H. Amaral. (2020) Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies. Journal of Controlled Release 320, pages 180-200.
Crossref
Tiankuan Li, Zhongqian Hu, Chao Wang, Jian Yang, Chuhui Zeng, Rui Fan & Jinhe Guo. (2020) PD-L1-targeted microbubbles loaded with docetaxel produce a synergistic effect for the treatment of lung cancer under ultrasound irradiation. Biomaterials Science 8:5, pages 1418-1430.
Crossref
Teoman Benli-Hoppe & Ernst Wagner. 2020. New Nanomaterials and Techniques for Tumor-targeted Systems. New Nanomaterials and Techniques for Tumor-targeted Systems 371 411 .
Begum Dariya, Eluri Pavitra, Saimila Momin & Ganji Seeta Rama Raju. 2020. Theranostics Approaches to Gastric and Colon Cancer. Theranostics Approaches to Gastric and Colon Cancer 231 250 .
Ghazal Farahavar, Samira Sadat Abolmaali, Nasser Gholijani & Foroogh Nejatollahi. (2019) Antibody-guided nanomedicines as novel breakthrough therapeutic, diagnostic and theranostic tools. Biomaterials Science 7:10, pages 4000-4016.
Crossref
Abbas H. Azandaryani, Soheila Kashanian & Tahereh Jamshidnejad-Tosaramandani. (2019) Recent Insights into Effective Nanomaterials and Biomacromolecules Conjugation in Advanced Drug Targeting. Current Pharmaceutical Biotechnology 20:7, pages 526-541.
Crossref
Praful R. Nair. (2019) Delivering Combination Chemotherapies and Targeting Oncogenic Pathways via Polymeric Drug Delivery Systems. Polymers 11:4, pages 630.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.